Incyte Corporation (INCY) vs West Pharmaceutical Services, Inc. (WST)
INCY leads on 16 of 16 compared metrics.
A side-by-side comparison of Incyte Corporation and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 27, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
INCY
Incyte Corporation
$113.75Healthcare
WST
West Pharmaceutical Services, Inc.
$350.85Healthcare
Total return — INCY vs WST
growth of $100 · last 30yINCY +1163.9%WST +5121.0%WST compounded faster
INCY WST
INCY vs WST: by the numbers
- •WST is the larger company ($24.79B vs $22.73B market cap).
- •INCY trades at the lower earnings multiple (16.07 vs 46.84 P/E).
- •INCY converts more revenue to profit (26.71% vs 16.85% net margin).
- •INCY grew revenue faster over the past five years (14.68% vs 6.72% CAGR).
- •WST pays a dividend (0.25% yield) while INCY does not currently pay one.
Which is better, INCY or WST?
Metric tally: INCY 16 · WST 0It depends on what you're optimizing for:
ValueINCY(lower P/E)
GrowthINCY(faster 5Y revenue CAGR)
QualityINCY(higher ROIC)
Metrics side by side
Valuation
| Metric | INCY | WST |
|---|---|---|
| P/E ratio | 16.07● | 46.84 |
| Forward P/E | 12.77● | 36.63 |
| P/S ratio | 4.39● | 7.89 |
| P/B ratio | 4.24● | 8.49 |
| PEG ratio | 0.76● | 33.99 |
| EV / EBITDA | 13.01● | 29.94 |
| FCF yield | 6.17%● | 1.80% |
Profitability
| Metric | INCY | WST |
|---|---|---|
| Gross margin | 92.48%● | 36.24% |
| Operating margin | 27.05%● | 20.67% |
| Net margin | 26.71%● | 16.85% |
| ROE | 25.79%● | 18.15% |
| ROIC | 20.58%● | 13.62% |
Dividends
| Metric | INCY | WST |
|---|---|---|
| Dividend yield | — | 0.25% |
| Payout ratio | — | 12.88% |
Growth (annualized)
| Metric | INCY | WST |
|---|---|---|
| Revenue CAGR (5Y) | 14.68%● | 6.72% |
| EPS CAGR (5Y) | 21.19%● | 7.85% |
| FCF CAGR (5Y) | 20.60%● | 8.32% |
| Total return CAGR (5Y) | 5.55%● | -0.26% |
Frequently asked
- Which is better, INCY or WST?
- It depends on your goal. value: INCY (lower P/E); growth: INCY (faster 5Y revenue CAGR); quality: INCY (higher ROIC). Across all compared metrics, INCY leads 16 to 0.
- Is INCY or WST cheaper?
- On trailing earnings, INCY is cheaper: INCY trades at a 16.07 P/E and WST at 46.84.
- Which has grown faster, INCY or WST?
- Over the past five years, INCY grew revenue faster — INCY at a 14.68% CAGR versus WST at 6.72%.
- Does INCY or WST pay a bigger dividend?
- WST pays a dividend (0.25% yield) while INCY does not currently pay one.
- Is INCY or WST more profitable?
- INCY runs the higher net margin — INCY at 26.71% versus WST at 16.85%.
- Which has been the better investment, INCY or WST?
- Over the past 10-year, WST delivered the higher annualized total return — INCY at 3.98% versus WST at 17.45%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Incyte P/E ratioWest Pharmaceutical Services P/E ratioIncyte dividend yieldWest Pharmaceutical Services dividend yieldIncyte ROEWest Pharmaceutical Services ROEIncyte operating marginWest Pharmaceutical Services operating marginIncyte revenue growthWest Pharmaceutical Services revenue growthIncyte free cash flowWest Pharmaceutical Services free cash flow
Incyte & West Pharmaceutical Services appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 27, 2026.